First Patients Treated In India Using Cyberknife Radiosurgery

< BACK TO COMPANY starstarstarstarstar   Business - Company Press Release
4th April 2009, 08:38am - Views: 943





Business Company Accuray Incorporated 1 image

Business Company Accuray Incorporated 2 image






First Patients Treated in India Using CyberKnife Radiosurgery


SUNNYVALE, Calif., Apr. 3 /PRNewswire-AsiaNet/ --


  Newly Installed System at Apollo Hospital Treats Six and Preps Eight Patients in First Week


    Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that

the first patients in India have been treated using CyberKnife radiosurgery. The CyberKnife System, which is

located at the Apollo Specialty Cancer Hospital in Chennai, India, treated six patients in its first week of

operation, with eight more patients in the treatment planning process being readied for treatment.


    "Our new CyberKnife System allows us to deliver highly precise radiosurgical treatments to patients with

tumors throughout the body," said Prathap C. Reddy, M.D., executive chairman, Apollo Hospitals Group. "We

are very glad to have begun treating patients and look forward to witnessing the benefits that the System

offers, including real-time tracking of tumors that move with respiration."


    The CyberKnife treatment team at Apollo Hospital consists of a trained team of highly experienced radiation

oncologists, radiation therapists and a neurosurgeon. The team plans to focus on CyberKnife radiosurgery for

lung, liver and prostate treatment as well as head, neck and spine treatments. Lung cancer is currently one of

the leading cancer incidences and causes of death amongst men in India. (National Cancer Registry, ICMR-

New Delhi)


    "Since India is the second most populous nation in the world, we are excited that CyberKnife radiosurgery is

now an option for its population and that the first patients have received treatment," said Eric P. Lindquist,

senior vice president and chief marketing officer at Accuray. "We believe this is just the first step in the

opening of a large market for the CyberKnife System, as illustrated by the momentum within this System's first

week of use."


    Advanced Medical Systems (headquartered in Singapore), the company responsible for placing the

CyberKnife at Apollo Hospital, will assist in marketing and providing end user support for the new CyberKnife

System through its Accuray trained team of engineers and applications specialists based in India.


    About Apollo Hospitals 

    It was in 1983 that Dr. Prathap Reddy made a pioneering endeavor by launching India's first corporate

hospital - Apollo Hospital in Chennai. An integrated healthcare company, the group has around 10,000 beds

across 45 hospitals, more than 750 pharmacies and 100 diagnostic clinics, medical business process

outsourcing services, health insurance services, and clinical research divisions with a focus on epidemiological

studies, stem cell research and genetic research. To develop talent for the burgeoning need of superior

healthcare delivery, the group has 10 nursing and hospital management colleges. Harnessing technology to

enhance access across India and share the repository of knowledge, there are more than 100 telemedicine



    About the CyberKnife(R) Robotic Radiosurgery System

    The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to

treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer

controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and

patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-

dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates

the need for invasive head or body stabilization frames.


    About Accuray

    Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of

radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those

diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which

extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate,

liver and pancreas. To date, the CyberKnife System has been used to treat more than 60,000 patients

Business Company Accuray Incorporated 3 image

worldwide and currently more than 155 systems have been installed in leading hospitals in the Americas,

Europe and Asia. For more information, please visit www.accuray.com


    Safe Harbor Statement 

    The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including

uncertainties associated with the medical device industry. Except for the historical information contained

herein, the matters set forth in this press release, including statements relating to commercialization of

products, regulatory review and approval and clinical studies are forward-looking statements within the

meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-

looking statements speak only as of the date the statements are made and are based on information available

at the time those statements are made and/or management's good faith belief as of that time with respect to

future events. You should not put undue reliance on any forward-looking statements. Important factors that

could cause actual performance and results to differ materially from the forward-looking statements we make

include: market acceptance of products; competing products, the combination of our products with

complementary technology; and other risks detailed from time to time under the heading "Risk Factors" in our

report on Form 10-K for the 2008 fiscal year, as updated in our Form 10-Q filed on February 5, 2009 and our

other filings with the Securities and Exchange Commission. The Company's actual results of operations may

differ significantly from those contemplated by such forward-looking statements as a result of these and other

factors. We assume no obligation to update forward-looking statements to reflect actual performance or

results, changes in assumptions or changes in other factors affecting forward-looking information, except to

the extent required by applicable securities laws.


SOURCE: Accuray Incorporated


    CONTACT:  Stephanie Tomei,

                        Senior Manager, 

                        Public Relations of Accuray Incorporated, 

                        +1-408-789-4234, 

                        stomei@accuray.com; 


                        or Brianne Donahue of Schwartz Communications,

                        +1-415-817-2545, 

                        bdonahue@schwartz-pr.com, 

                        for Accuray Incorporated

    (ARAY)


__________________________________________________________________________________________

To view this and other AsiaNet releases please visit http://www.asianetnews.net






news articles logo NEWS ARTICLES
Contact News Articles |Remove this article